Roles of CCL2 and CCL3 in intraocular inflammation during Bacillus endophthalmitis

Exp Eye Res. 2022 Nov:224:109213. doi: 10.1016/j.exer.2022.109213. Epub 2022 Sep 2.

Abstract

Bacillus cereus (B. cereus) endophthalmitis is a vision-threatening bacterial infection. Uncontrolled inflammatory responses are the hallmark of this disease which cause irreversible damage to the retina. We recently reported C-X-C chemokines as a vital modulators which impacted the pathogenesis of this disease. Here, we investigated the impact of two highly upregulated C-C chemokines, CCL2 and CCL3, on intraocular inflammation this disease. B. cereus was injected into the eyes of C57BL/6J (WT), CCL2-/-, and CCL3-/- mice to induce endophthalmitis. Infected eyes were examined for bacterial growth, retinal function, and inflammation. Bacterial growth in CCL2-/- and CCL3-/- mice were similar, but retained retinal function was greater in CCL2-/- and CCL3-/- eyes compared to that of C57BL/6J eyes. The retinal architecture of infected eyes of CCL2-/- mice were conserved for a longer period of time than in infected CCL3-/- eyes. Infected CCL2-/- and CCL3-/- eyes had less inflammation than did infected C57BL/6J eyes. Based on these results, we assessed the efficacies of intravitreal anti-CCL2 or anti-CCL3 with or without the antibiotic gatifloxacin. Compared to infected untreated eyes, there was significantly less inflammation and greater retention of retinal function in eyes treated with anti-CCL2 or anti-CCL3 with gatifloxacin. This study showed that B. cereus endophthalmitis in CCL2-/- mice had a better clinical outcome than in CCL3-/- mice. Intravitreal administration of anti-CCL2 and anti-CCL3 with gatifloxacin significantly reduced inflammation and provided protection of retinal function. These results suggest that CCL2 and CCL3 are prospective anti-inflammatory targets that should be tested along with other antibiotics for treating Bacillus and perhaps other forms of endophthalmitis.

Keywords: Bacillus cereus; Chemokine; Endophthalmitis; Immune responses; Inflammation; Ocular infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Bacillus cereus
  • Bacillus*
  • Chemokine CCL2* / genetics
  • Chemokine CCL3 / genetics
  • Electroretinography
  • Endophthalmitis* / drug therapy
  • Endophthalmitis* / microbiology
  • Eye Infections, Bacterial* / drug therapy
  • Eye Infections, Bacterial* / microbiology
  • Gatifloxacin / therapeutic use
  • Inflammation
  • Mice
  • Mice, Inbred C57BL
  • Uveitis*

Substances

  • Anti-Bacterial Agents
  • Ccl3 protein, mouse
  • Chemokine CCL3
  • Gatifloxacin
  • Ccl2 protein, mouse
  • Chemokine CCL2